Stay updated on Long-Acting vs Daily rhGH in Children Clinical Trial

Sign up to get notified when there's something new on the Long-Acting vs Daily rhGH in Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Acting vs Daily rhGH in Children Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now presents the completed Phase 3 trial of long-acting somavaratan versus daily growth hormone in children, including eligibility criteria, treatment arms, outcomes, and study documents.
    Difference
    48%
    Check dated 2026-11-09T11:46:15.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:45:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH announcement banner links to transition updates and says federal agencies are replacing the term “Artificial Intelligence” with “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T12:52:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T13:35:31.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:17:47.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Accessing the study record now yields a 403 Forbidden error page, replacing the previous study details and documents with a standard error screen and site footer. This indicates a shift from content availability to an access-denied presentation, consistent with an error state rather than substantive page updates.
    Difference
    18%
    Check dated 2026-09-21T22:05:31.000Z thumbnail image

Stay in the know with updates to Long-Acting vs Daily rhGH in Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Acting vs Daily rhGH in Children Clinical Trial page.